Correction: Pan et al. Therapeutic Potential of BMX-001 for Preventing Chemotherapy-Induced Peripheral Neuropathic Pain. Pharmaceuticals 2025, 18, 1159
Tianshu Pan, Olawale A. Alimi, Bo Liu, Mena A. Krishnan, Mitchell Kuss, Wei Shi, Jairam Krishnamurthy, Jianghu James Dong, Rebecca E. Oberley-Deegan, Bin Duan
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPain Mechanisms and Treatments · Nerve injury and regeneration · Cancer Treatment and Pharmacology
Citation Correction
In the original publication [1], Section “3. Discussion”. Original sentence: “In ovarian cancer models, co-treatment with BMX-001 and PTX significantly reduced the cell viability of CAOV2 cells compared to PTX alone and downregulated the expression of BCL2, NF-κB, and IL-1β [49].”
Original citation for [49] is “Batinic-Haberle, I.; Tovmasyan, A.; Veade, A.; Spasojevic, I.; Reihani, S.; Secord, A. Mn porphyrin/ascorbate sensitizes serous epithelial ovarian cancer to chemotherapy. Free. Radic. Biol. Med. 2018, 128, S74–S75.” It has been correctly replaced with [2].
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Pan T. Alimi O.A. Liu B. Krishnan M.A. Kuss M. Shi W. Krishnamurthy J. Dong J.J. Oberley-Deegan R.E. Duan B. Therapeutic Potential of BMX-001 for Preventing Chemotherapy-Induced Peripheral Neuropathic Pain Pharmaceuticals 202518115910.3390/ph 1808115940872550 PMC 12389141 · doi ↗ · pubmed ↗
- 2Spasojevic I. da Silva W.T.A. Huang Z. Duan W. Du L. Chen C. Cao J. Zhang S. Lee H. Lo G. Redox-active Mn porphyrin-based clinical candidate, Mn Tn Bu OE-2-Py P 5+ (BMX-001) reduces paclitaxel-induced neuropathy, while suppressing ovarian cancer growth Free Radic. Biol. Med.2024224 S 54S 5510.1016/j.freeradbiomed.2024.10.117 · doi ↗